These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34100183)

  • 1. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
    Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
    Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.
    Hu X; Xu M; Hu Y; Li N; Zhou L
    Cell Biochem Biophys; 2021 Jun; 79(2):397-405. PubMed ID: 33743142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3.
    Zhao J; Lei T; Xu C; Li H; Ma W; Yang Y; Fan S; Liu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):439-44. PubMed ID: 23916610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.
    Wang L; Kang FB; Sun N; Wang J; Chen W; Li D; Shan BE
    Tumour Biol; 2016 Nov; 37(11):14939-14947. PubMed ID: 27644254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
    Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
    Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
    Xu H; Cheung IY; Guo HF; Cheung NK
    Cancer Res; 2009 Aug; 69(15):6275-81. PubMed ID: 19584290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
    Nygren MK; Tekle C; Ingebrigtsen VA; Mäkelä R; Krohn M; Aure MR; Nunes-Xavier CE; Perälä M; Tramm T; Alsner J; Overgaard J; Nesland JM; Borgen E; Børresen-Dale AL; Fodstad Ø; Sahlberg KK; Leivonen SK
    Br J Cancer; 2014 Apr; 110(8):2072-80. PubMed ID: 24577056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer.
    Deng M; Wu D; Zhang Y; Jin Z; Miao J
    Gynecol Oncol; 2021 Jul; 162(1):190-199. PubMed ID: 33875234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
    Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
    J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
    Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
    Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma.
    Pathania AS; Chava H; Chaturvedi NK; Chava S; Byrareddy SN; Coulter DW; Challagundla KB
    Cell Death Dis; 2024 Jun; 15(6):428. PubMed ID: 38890285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.
    Huang L
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6759-6766. PubMed ID: 32633367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients.
    Lee H; Kim JH; Yang SY; Kong J; Oh M; Jeong DH; Chung JI; Bae KB; Shin JY; Hong KH; Choi I
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1445-52. PubMed ID: 20140740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H3 overexpression in pancreatic cancer promotes tumor progression.
    Zhao X; Li DC; Zhu XG; Gan WJ; Li Z; Xiong F; Zhang ZX; Zhang GB; Zhang XG; Zhao H
    Int J Mol Med; 2013 Feb; 31(2):283-91. PubMed ID: 23242015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.
    Wang J; Chong KK; Nakamura Y; Nguyen L; Huang SK; Kuo C; Zhang W; Yu H; Morton DL; Hoon DS
    J Invest Dermatol; 2013 Aug; 133(8):2050-8. PubMed ID: 23474948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.
    Weissmann-Brenner A; Kushnir M; Lithwick Yanai G; Aharonov R; Gibori H; Purim O; Kundel Y; Morgenstern S; Halperin M; Niv Y; Brenner B
    Int J Oncol; 2012 Jun; 40(6):2097-103. PubMed ID: 22426940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.